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ABSTRACT 
Novel dosage forms emerges more and more in recent years. One of them is liquid-filled hard gelatin capsules, which have gelatin or the 
hydroxypropyl methyl cellulose (HPMC) as capsule shell. The liquid-filled hard gelatin capsule is gradually getting attention because of its new-
concept dosage form design, which bring liquid drugs by solid form. The paper mostly presents application, pharmaceutical manufacturing, 
quality assessment, vision of liquid-filled hard gelatin capsules and emphases on the application and pharmaceutical manufacturing of liquid-
filled capsule. It is recommended that the capsule is suitable for many liquid or semi-solid natural plant extract and achieve different release 
profiles. The preparation adopted liquid-filled hard capsules technology. The impact factors concluded property of shell and device of filling. 
The quality was frequently evaluated by moisture content of capsule shell, dissolution rate. At the same time, it was pointed out that the new 
dosage form has remarkable marketing prospect and bring profits for enterprises. 
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Introduction 
Liquid filled hard gelatin capsule are well recognized as a 
solid dosage form for convenient administration of drugs 
orally in a liquid form. Liquid filled capsule technology can be 
used for liquid and semisolid fills in hard gelatin or HPMC 
capsule with or without banding. This liquid composition 
available help the most challenging drug compounds in 
capsules has increased significantly in recent years. In 
particular it is possible to solubilize many drug compounds 
in a micro emulsion pre-concentrate inside the hard gelatin 
capsules such that on subsequent dispersion in the gastro 
intestinal tract, the drug remains in solution. It is considered 
that this technology can make a significant contribution to 
the development of efficacious pharmaceutical products by 
providing the flexibility to rapidly develop and test in – 
house formulation when small quantities of drug is available.  
The Hard gelatin capsule has historically been used as a 
dosage form for pharmaceutical and Nutraceutical products 
that are formulated as powders or pellets. Liquid-fill hard 
gelatin capsule technology was established in the early 
1980s as an alternative to soft gelatin capsules and offered a 
number of specific advantages such as lower moisture and 
gas transmission, use of high melting point excipients, 
plasticizer- and preservative-free, lower moisture content, 
ease of coating and choice of capsule composition (gelatin 
and hydroxypropyl methylcellulose). This technology is 
mostly suitable for insoluble compounds, highly potent 
compounds. Once the capsule is filled, they are sealed by 
spraying small amount of Water/ethanol mixture at the cap 
and body interface followed by gentle warming to fuse the 
two parts of capsule together or by band sealing of capsule 
with gelatin or cellulose.  
Drugs having low melting points or are liquids at room 
temperatures which have difficulty when formulated as dry 
powders and often requires high concentration of excipients 
to avoid processing problems. The hard gelatin capsule has 
been conventionally used for Rx and OTC drugs and herbal 
products, which are formulated as a powder or pellets. 
Various categories of drugs, however, demand new and 
different ways of formulation and the market demands that 
these products are developed and launched in an ever 
decreasing time period. This article will review how liquids 
filled into hard gelatin capsules can achieve some of these 
difficulties and will review the categories of drugs for which 
the liquid capsule is particularly suitable and also study the 
compatibility problems associated with excipients, compare 
the liquid filled and sealed hard gelatin capsule with soft 
gelatin capsules and describe a new process for sealing hard 
gelatin capsules.1 
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Drug categories suitable for Liquid filled capsules 
1. Drugs with Poor bioavailability: The bioavailability of the 
poorly water-soluble drugs can be significantly enhanced 
when formulated as a liquid in a hard gelatin capsule.(2-3) 
2. Drugs with Low melting point: Materials having low 
melting points or are liquid at room temperature have some 
problems when formulating as dry powders, often requiring 
high concentrations of excipient to avoid processing 
problems. (4) 
3. Potent drugs:  Drugs in this category present two main 
challenges; content uniformity and cross-contamination and 
worker protection. (5,6) 
4. Sustained release drug candidates: By choosing an 
appropriate excipient the release rate of an active ingredient 
can be modified. E.g., soybean oil and glyceryl monostearate. 
(7)  
 
Figure 1: Reasons for Formulating Drugs as Liquid Dosage 
Forms 
Compatibility of Fill Materials  
The properties of the API which shows whether it is a good 
candidate for liquid filling or not. The suitable excipients are 
evaluated by considering that neither the API nor the 
excipients should cause the gelatin shell to gain or lose 
excessive moisture, which can cause the shell to lose its 
mechanical strength. All substances must also be chemically 
compatible with gelatin. To maintain flexibility, the capsule 
shell should have the moisture content ranging 13-16%. 
Below that range capsules become brittle and are prone to 
breakage. Above that range the capsules may deform. To 
measure the moisture exchange between the fill material and 
the shell, fill the capsules with the product and store them at 
different levels of relative humidity (RH) (i.e., 2.5, 10, 30, 50 
and 60%) for 2 weeks. During that period, the moisture 
exchange across the range of RHs should not exceed ±2%.(8)   
Fill materials that exchange more than ±2% moisture 
compared to empty shells stored under the same conditions 
as liquid filling. The capsule’s mechanical resistance must be 
checked with relation to moisture content. This involves 
storing the filled capsules for 1week at different RHs and 
then testing them for resistance to breakage and 
deformation. The chemical compatibility of the fill material 
with the gelatin shell is also important. If there is a cross 
linking between fill material and the protein chains of the 
gelatin may causes delay in dissolution. One method of 
monitoring cross- linking is to first store the fill material 
inside the hard gelatin capsules under ICH accelerated 
storage conditions (40°C at 75% RH) and then substitute the 
fill material with acetaminophen. And then conduct a 
dissolution test according to USP guidelines to compare the 
dissolution profiles of filled and unfilled capsules stored at 
the accelerated conditions.(9) 
 
Table 1: Excipients for liquid filled hard gelatin capsule 
 Refined specially oils Arachis oil, Castor oil, Cotton seed oil, Olive oil, Soyabean 
Lipophilic   oil, Sesame oil, Maize(corn)oil and sun flower oil 
liquid vehicles   Akomed R (Caprylic/capric triglycerides) 
 Medium chain Miglyol 810 (actoic acid/capric triglyceride) 
 Triglycerides  Miglyol829 (succinic triglyceride) 
   Miglyol840 (propanediol dioctanoate/dicaprate) 
   Softisan645 (bis polyacyladipic diglyceride1) 
   Lauroglycol FCC (Propylene Glycol Laurate), Captex 355 
   
Semisolid Hydrogenated oils Arachis oil (Groundnut 36), Castor oil (Cutina HR), 
Lipophilic   Cottonseed oil (Sterotex) and Palm oil (Softisan 154) 
Vehicles Waxes  Cetosteryl alcohol, Cetyl alcohol and Steryl alcohol 
 Gelucires  Gelucires 33/01, 39/01, 43/01 
 Solubilizing    agents, Emulsifiers-  Imwitor 780K(Isostearyl Diglyceryl Succinate) 
 
W/O emulsifier,  Imwitor 380 (Glyceryl Cocoate/Citrate/Lactate) 
 surfactants, O/W emulsifier   
 Emulsifying 
 Agents Surfactants  Tween 80, Poloxamer 124 and poloxamer 188 
  
 Plurol Oleique CC497 (Polyglyceryl Oleate ) 
 
Fatty acid esters 
Liquid solubilizer  Softigen 701(Glyceryl Ricinoleate) 
   Softigen 767(PEG-6 Caprylic/Capric Glycerides) 
 Polyethylene Glycols PEG>4000 
 Gelucires  Gelucire 44/14, 50/13 
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                 Table 2: Size and volumes of hard gelatin capsules for liquid filling 
Size (ml) Approx. volume (ml) Approx. available volume 
00el 0.92 0.83 
00 0.85 0.77 
0 0.61 0.55 
1 0.45 0.41 
2 0.34 0.31 
 
 
Capsule filling 
Capsugels are capsule especially designed for liquid and 
semi-solid fillings (10). This capsule is longer than standard 
capsules, so that when the capsule body and cap are fully 
joined, the top of the capsule body’s wall contacts the 
interior of the cap. This provides the primary barrier to 
prevent the liquid fill from escaping. As it is essential to keep 
the area of the cap-body interface uncontaminated by fill 
material, otherwise it is virtually impossible to seal the 
capsule. To further prevent or reduce leakage and 
contamination at the cap-body interface, the capsule has no 
side air vents, which are of typical capsules used in high-
speed powder filling. The capsule is normally filled to no 
more than 90% of its volume to minimize the chance of the 
liquid fill contaminating the cap-body interface. (11)  
Recommended specifications for filling liquids into hard 
gelatin capsules  
1. Temperature of fill material: Max 700C  
2. Viscosity: 0.1 – 1Pa s  
3. Particle size of suspended particle: <50µm  
4. Visco properties: Clean break from dosing nozzle 
A brief comparison of sealing methods: 
Once closed, the capsule must be sealed to avoid leaks and 
tampering. A hydro-alcoholic fusion process (described in 
the USP’s capsule monograph) is one method of sealing. This 
fusion procedure starts with an application of less than 50 
microliters of sealing solution to the cap-body interface. The 
solution enters the overlapping cap and body by capillary 
action while a vacuum removes excess sealing fluid from the 
capsule. Next is the gentle application of warm (40° to 60°C) 
air fuses the gelatin of the cap and body together and 
evaporates the sealing solution. The complete procedure 
takes less than 1 minute and converts the two-piece hard 
capsule into a leak-free dosage unit. Once sealed, the capsule 
meets tamper-evidence guidelines since it cannot be opened 
without visibly altering it.  
Another method involves banding the cap-body interface 
with a thin film of gelatin. Banding involves several added 
tasks compared with hydroalcoholic sealing. First prepare 
the gelatin bath and its viscosity must be checked 
continuously. Care should be taken as there is a risk of 
microbiological contamination associated with warm liquid 
gelatin. Furthermore, the gelatin band can cause physical 
defects in the capsule such as bubbles may form in the 
gelatin band or the capsules may take on a “banana” shape. 
The deformation usually occurs when the warm band of 
gelatin cools and the capsules are subjected to a long drying 
cycle. (12) 
 
Figure 2: Steps involved in sealing technique
 
Table 3: Currently marketed products formulated as liquid fill capsules 
Sr no: Active Brand Dosage form License holder 
1 Danthron Co-Danthromer Hard capsule Napp 
2 Captopril Captopril-R Hard capsule Sankyo 
3 Peppermint oil Colpermin Hard capsule J & J 
4 Isotretinion Claravis Hard capsule Teva 
5 Mebeverine Mebeverine Hard capsule Mylan 
6 Paricalcitol Zemplar Soft gel Abbott 
7 Dutasteride Avodart Soft gel GSK 
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Evaluation parameters of liquid filled capsules  
1. Content uniformity of liquid filled capsules:  
The content uniformity of optimized formulation filled 
capsules is performed by assay method. For this test sample 
of the contents is assayed as described in individual 
monograph and values calculated comply with prescribed 
standards. The content uniformity should be in the limit 
indicating result for assay lay in the range. Content 
uniformity or assay studies were also done for all capsules at 
specific intervals showed that drug was uniformly 
distributed. (13) 
2. In vitro dissolution profiles:   
Drug release from the liquid filled hard gelatin capsules is 
evaluated by carrying out dissolution studies in specific 
solvent using USP II type (paddle type) dissolution tester 
(Electro Lab, India).The speed of rotations is at 50 RPM. 
Temperature should maintain at 370C. The absorbance is 
measured in UV Spectrophotometry at drug’s absorbance 
maxima. Dissolution study of the formulation should 
compare with marketed preparation. (14)  
 3. Drug content 
The drug content of liquid filled hard Gelatin capsules was 
determined spectrophotometrically by using UV 
spectrophotometer. The percentage content of LFHGC: Assay 
value X 100/ Label claim. (14) 
4. Sealing integrity / Leak test:   
Leak test should perform and all the capsules have to pass 
the leak test. By repeating the sealing integrity or leak test 
for all those capsules at specific intervals showed that there 
was no leakage it conforms that the seal was not broken or 
disturbed such that the capsules were stable. (14) 
5. Weight variation test 
Fill the capsule shell with formulation. Take 20 capsules and 
weight of individual capsule should be noted and average 
weight is calculated. Not more than two individual weight 
deviates from average weight. (15) 
6. Disintegration test 
For performing disintegration test on capsules, the tablet 
disintegration test apparatus is used but the guiding disc 
may not be used except that the capsules float on top of the 
water. One capsule is placed in each tube which are then 
suspended in the beakers to move up and down for 30 
minutes, unless otherwise stated in the monograph. The 
capsules pass the test if no residue of drug or other than 
fragments of shell remains on No. 10 mesh screen of the 
tubes. (16) 
7. Stability studies:   
Preliminary stability of the best formulation obtained by 
investigating its Physical characteristics and drug content 
and drug release after storage at stressed conditions. LFHGC 
was stored at 400C & 75% RH for a period of 1months. The 
Physical characteristics and drug content and drug release of 
the fresh (stored at room temperature) and stressed 
preparations are compared to evaluate the stability and 
effect of aging.  A moisture uptake studies at 75% RH should 
be conducted to know the stability of empty capsules and the 
formulation filled capsules. The moisture pickup should not 
be more than 2% as they were found to split and not 
acceptable. (16)   
Conclusion  
Liquid formulations filled into two-piece hard capsules is the 
topic of interest in the pharmaceutical industry over the last 
decade. Today’s challenges in product development due to 
the poor aqueous solubility and high potency of the new 
molecules are being addressed by some development groups 
that are focused on liquid formulations. In-house filling and 
sealing these formulations into two-piece hard gelatin 
capsules can be done easily with today’s equipment. The 
processes have also been proven to be commercially viable 
for in-house manufacturing. Many pharmaceutical products 
now under development are expected to reach the market 
within the upcoming years and increasing the number of 
commercial products using a liquid-filled and sealed capsule. 
Liquid filling and sealing of hard gelatin capsules thus 
become a much more possible option. It provides the 
formulation scientist with an in-house option to rapidly 
develop products for clinical trials when drug substance is at 
a premium and also provides an easy way to scale-up and 
production. 
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